Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Lichen planus-type chronic graft-versus-host disease complicated by mucous membrane pemphigoid with positive anti-BP180/230 and scleroderma-related autoantibodies followed by reduced regulatory T cell frequency.

Hanafusa T, Azukizawa H, Nishioka M, Tanemura A, Murota H, Yoshida H, Sato E, Hashii Y, Ozono K, Koga H, Hashimoto T, Katayama I.

Eur J Dermatol. 2012 Jan-Feb;22(1):140-2. doi: 10.1684/ejd.2011.1587. No abstract available.

PMID:
22217601
2.

Clinical and immunological factors associated with bullous pemphigoid relapse.

Fine JD.

JAMA Dermatol. 2014 Jan;150(1):34. doi: 10.1001/jamadermatol.2013.8090. No abstract available.

PMID:
24226151
3.

Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study.

Fichel F, Barbe C, Joly P, Bedane C, Vabres P, Truchetet F, Aubin F, Michel C, Jegou J, Grange F, Antonicelli F, Bernard P.

JAMA Dermatol. 2014 Jan;150(1):25-33. doi: 10.1001/jamadermatol.2013.5757.

PMID:
24226428
4.

Lichen planus pemphigoides with circulating autoantibodies against 200 and 180 kDa epidermal antigens.

Yoon KH, Kim SC, Kang DS, Lee IJ.

Eur J Dermatol. 2000 Apr-May;10(3):212-4.

PMID:
10725820
5.

[Bullous pemphigoid: diagnosis and therapy].

Kneisel A, Hertl M.

Wien Med Wochenschr. 2014 Sep;164(17-18):363-71. doi: 10.1007/s10354-014-0294-9. Epub 2014 Jul 31. Review. German.

PMID:
25077677
6.

Lichen planus pemphigoides: identification of 180 kd hemidesmosome antigen.

Tamada Y, Yokochi K, Nitta Y, Ikeya T, Hara K, Owaribe K.

J Am Acad Dermatol. 1995 May;32(5 Pt 2):883-7.

PMID:
7722050
7.

Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.

Ishiura N, Fujimoto M, Watanabe R, Nakashima H, Kuwano Y, Yazawa N, Echigo T, Okochi H, Tamaki K.

J Dermatol Sci. 2008 Feb;49(2):153-61. Epub 2007 Oct 24.

PMID:
17920818
8.

Lichen planus pemphigoides with IgG autoantibodies to the 180 kd bullous pemphigoid antigen (type XVII collagen).

Hsu S, Ghohestani RF, Uitto J.

J Am Acad Dermatol. 2000 Jan;42(1 Pt 1):136-41.

PMID:
10607335
9.

Occurrence of circulating anti-bullous pemphigoid antibodies in patients with lichen sclerosus.

Gambichler T, Höxtermann S, Skrygan M, Eberz B, Regauer S, Scola N, Kreuter A.

J Eur Acad Dermatol Venereol. 2011 Mar;25(3):369-70. doi: 10.1111/j.1468-3083.2010.03739.x. No abstract available.

PMID:
20524944
10.

Case of pemphigoid vegetans positive with both BP180 and BP230 in enzyme-linked immunosorbent assays.

Nagamoto E, Fujisawa A, Jinnin M, Koga H, Ishii N, Hashimoto T, Yoshino Y.

J Dermatol. 2014 Jul;41(7):667-8. doi: 10.1111/1346-8138.12523. No abstract available.

PMID:
24985550
11.

Blistering insights into the pathogenesis of bullous pemphigoid.

Wong HK, Bechtel MA.

Clin Immunol. 2012 Feb;142(2):101-4. doi: 10.1016/j.clim.2011.12.003. Epub 2011 Dec 13. No abstract available.

PMID:
22217422
12.

Lichen planus pemphigoides evolving into pemphigoid nodularis.

Sakuma-Oyama Y, Powell AM, Albert S, Oyama N, Bhogal BS, Black MM.

Clin Exp Dermatol. 2003 Nov;28(6):613-6.

PMID:
14616828
13.

Concurrence of autoantibodies to bullous pemphigoid antigens and desmoglein 3: analysis of pathogenic and nonpathogenic antibodies.

Ono S, Tanioka M, Tanizaki H, Fujisawa A, Koga H, Hashimoto T, Kamiya K, Aoyama Y, Iwatsuki K, Miyachi Y.

Br J Dermatol. 2013 Jun;168(6):1357-60. doi: 10.1111/bjd.12143. No abstract available.

PMID:
23738642
14.

Bullous pemphigoid-like eruption subsequent to scabies: bullous scabies or bullous pemphigoid?

Huang MX, Li ZS, Luo DQ, Lin Q.

G Ital Dermatol Venereol. 2015 Jun;150(3):337-9. Epub 2015 Feb 6. No abstract available.

PMID:
25658439
15.

Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180.

Zillikens D, Caux F, Mascaro JM, Wesselmann U, Schmidt E, Prost C, Callen JP, Bröcker EB, Diaz LA, Giudice GJ.

J Invest Dermatol. 1999 Jul;113(1):117-21.

16.

Association of autoantibodies to BP180 with disease activity in Greek patients with bullous pemphigoid.

Patsatsi A, Kyriakou A, Pavlitou-Tsiontsi A, Giannakou A, Sotiriadis D.

Clin Dev Immunol. 2012;2012:854795. doi: 10.1155/2012/854795. Epub 2012 Nov 27.

17.
18.

[Bullous pemphigoid].

Ohyama M, Amagai M.

Ryoikibetsu Shokogun Shirizu. 2000;(31):274-6. Review. Japanese. No abstract available.

PMID:
11269078
19.

IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.

Feldrihan V, Licarete E, Florea F, Cristea V, Popescu O, Sitaru C, Chiriac MT.

Hum Immunol. 2014 Apr;75(4):354-63. doi: 10.1016/j.humimm.2014.01.005. Epub 2014 Jan 24.

PMID:
24468586
20.

IgE recognition of bullous pemphigoid (BP)180 and BP230 in BP patients and elderly individuals with pruritic dermatoses.

Fania L, Caldarola G, Müller R, Brandt O, Pellicano R, Feliciani C, Hertl M.

Clin Immunol. 2012 Jun;143(3):236-45. doi: 10.1016/j.clim.2012.02.003. Epub 2012 Mar 13.

PMID:
22534318

Supplemental Content

Support Center